These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18006113)
1. Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin. Kim HR; Kim S; Kim EJ; Park JH; Yang SH; Jeong ET; Park C; Youn MJ; So HS; Park R Lung Cancer; 2008 Apr; 60(1):47-56. PubMed ID: 18006113 [TBL] [Abstract][Full Text] [Related]
2. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells. Kuroda H; Takeno M; Murakami S; Miyazawa N; Kaneko T; Ishigatsubo Y Lung Cancer; 2010 Jan; 67(1):31-6. PubMed ID: 19375813 [TBL] [Abstract][Full Text] [Related]
4. 2,3,5,6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-κB, AP-1 and MAPK pathways in human proximal tubular cells. Gong X; Ivanov VN; Hei TK Arch Toxicol; 2016 Sep; 90(9):2187-2200. PubMed ID: 26404762 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of heme oxygenase-1 enhances the chemosensitivity of laryngeal squamous cell cancer Hep-2 cells to cisplatin. Lv X; Song DM; Niu YH; Wang BS Apoptosis; 2016 Apr; 21(4):489-501. PubMed ID: 26801320 [TBL] [Abstract][Full Text] [Related]
6. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways. Do MT; Kim HG; Khanal T; Choi JH; Kim DH; Jeong TC; Jeong HG Toxicol Appl Pharmacol; 2013 Sep; 271(2):229-38. PubMed ID: 23707609 [TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways. Yang YC; Lii CK; Wei YL; Li CC; Lu CY; Liu KL; Chen HW J Nutr Biochem; 2013 Jan; 24(1):204-12. PubMed ID: 22901690 [TBL] [Abstract][Full Text] [Related]
8. Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin. So HS; Kim HJ; Lee JH; Lee JH; Park SY; Park C; Kim YH; Kim JK; Lee KM; Kim KS; Chung SY; Jang WC; Moon SK; Chung HT; Park RK Cell Death Differ; 2006 Oct; 13(10):1763-75. PubMed ID: 16485034 [TBL] [Abstract][Full Text] [Related]
9. Targeting Nrf2-mediated heme oxygenase-1 enhances non-thermal plasma-induced cell death in non-small-cell lung cancer A549 cells. Ma J; Yu KN; Cheng C; Ni G; Shen J; Han W Arch Biochem Biophys; 2018 Nov; 658():54-65. PubMed ID: 30248308 [TBL] [Abstract][Full Text] [Related]
10. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. Kweon MH; Adhami VM; Lee JS; Mukhtar H J Biol Chem; 2006 Nov; 281(44):33761-72. PubMed ID: 16950787 [TBL] [Abstract][Full Text] [Related]
11. miR-29b-3p targetedly regulates VEGF to inhibit tumor progression and cisplatin resistance through Nrf2/HO-1 signaling pathway in non-small cell lung cancer. Sun Z; Ren M; Niu J; Tang G; Li Y; Kong F; Song X Environ Toxicol; 2024 Jul; 39(7):3956-3966. PubMed ID: 38587027 [TBL] [Abstract][Full Text] [Related]
12. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020 [TBL] [Abstract][Full Text] [Related]
13. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells. Deng X; Rui W; Zhang F; Ding W Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690 [TBL] [Abstract][Full Text] [Related]
14. An IκBα phosphorylation inhibitor induces heme oxygenase-1(HO-1) expression through the activation of reactive oxygen species (ROS)-Nrf2-ARE signaling and ROS-PI3K/Akt signaling in an NF-κB-independent mechanism. Min KJ; Lee JT; Joe EH; Kwon TK Cell Signal; 2011 Sep; 23(9):1505-13. PubMed ID: 21620964 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of Khayandirobilide A from Khaya senegalensis via NF-κB, AP-1 and p38 MAPK/Nrf2/HO-1 signaling pathways in lipopolysaccharide-stimulated RAW 264.7 and BV-2 cells. Zhou MM; Zhang WY; Li RJ; Guo C; Wei SS; Tian XM; Luo J; Kong LY Phytomedicine; 2018 Mar; 42():152-163. PubMed ID: 29655681 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism. Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117 [TBL] [Abstract][Full Text] [Related]
17. Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1. So H; Kim H; Kim Y; Kim E; Pae HO; Chung HT; Kim HJ; Kwon KB; Lee KM; Lee HY; Moon SK; Park R J Assoc Res Otolaryngol; 2008 Sep; 9(3):290-306. PubMed ID: 18584244 [TBL] [Abstract][Full Text] [Related]
18. 4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells. Lim J; Lee SH; Cho S; Lee IS; Kang BY; Choi HJ Mol Cells; 2013 Oct; 36(4):340-6. PubMed ID: 24046186 [TBL] [Abstract][Full Text] [Related]
19. The cytoprotective effects of 7,8-dihydroxyflavone against oxidative stress are mediated by the upregulation of Nrf2-dependent HO-1 expression through the activation of the PI3K/Akt and ERK pathways in C2C12 myoblasts. Kang JS; Choi IW; Han MH; Kim GY; Hong SH; Park C; Hwang HJ; Kim CM; Kim BW; Choi YH Int J Mol Med; 2015 Aug; 36(2):501-10. PubMed ID: 26096841 [TBL] [Abstract][Full Text] [Related]
20. Sageretia thea Inhibits Inflammation through Suppression of NF- Kim HN; Park GH; Park SB; Kim JD; Eo HJ; Son HJ; Song JH; Jeong JB Am J Chin Med; 2019; 47(2):385-403. PubMed ID: 30834779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]